CTRI/2018/03/012313招募中未知
The spectrum of infection in post renal transplant recipients and its correlation with various risk factors: a prospective study
Ranjani Ravi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All post renal transplant patients seen as inpatients and in the outpatient department at KIMS hospital during the period August 2017 to July 2019 with evidence of infection
排除标准
- •Patients not compliant with immunosuppressive medications
- •Patients in rejection â?? acute or chronic
- •Patients with malignancy
- •Non consenting patients
研究者
相似试验
已完成
1 期
A study to compare low dose versus recommended dose of the anti viral drug valganciclovir in preventing cytomegalovirus infection in renal transplant recipientsCTRI/2018/06/014356Postgraduate Institute of Medical Education and research60
已完成
不适用
Infections After Renal Transplantation: Diseases Pattern in Hong KongKidney TransplantationInfectionNCT00498017Hospital Authority, Hong Kong58
进行中（未招募）
1 期
Polyomavirus BK nephropathy after renal transplantation: Randomized clinical trial to demonstrate that switching to mTOR inhibitor is more effective than a reduction of immunosuppressive therapy - POLYOMA STUDYPolyoma BK-virus nephropathy is a viral complication after renal transplantation attacking up to 10% of renal transplants and causing transplant failure in 45% of cases. No virustatic treatment exists. Modifying the infection is usually tried by lowering immunosuppression, which may lead to transplant failure by rejection as well. A randomized switch of immunosuppression to everolimus vs general lowering of immunosuppression has to be tested (prospect. random. parallel group comparison).EUCTR2008-005925-12-DEMedizinische Hochschule Hannover120
Unknown
不适用
Study of Subclinical Viral InfectionKidney TransplantationKidney Failure, ChronicNCT01615341Seattle Children's Hospital100
已完成
不适用
Immunomonitoring of stable renal transplantation patients receiving triple immunosuppressive therapyNL-OMON55264Centre for Human Drug Research20